NCT06182436 Virtual Reality for Pain Management During Dupilumab Injection Status RECRUITING Phase NA
NCT06176040 A Study of TAVO101 in Atopic Dermatitis Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06175143 A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis. Status NOT_YET_RECRUITING Phase PHASE1
NCT06174493 Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials Status NOT_YET_RECRUITING Phase N/A
NCT06169527 A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06162507 Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis Status COMPLETED Phase PHASE1/PHASE2
NCT06144424 Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06129136 The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients. Status COMPLETED Phase NA
NCT06119529 A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis Status TERMINATED Phase PHASE1
NCT06116565 A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis Status NOT_YET_RECRUITING Phase PHASE2
NCT06108570 Evaluation of the Efficacy of TOPIALYSE Baume Protect+ on Atopic Dermatis Status COMPLETED Phase NA
NCT06101823 Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis Status UNKNOWN Phase PHASE2
NCT06092762 A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06085521 A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06082323 A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers Status RECRUITING Phase PHASE1
NCT06063044 Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children Status COMPLETED Phase N/A